Tumor Virology

Tumor Virology: Tumor virology manages the precise contamination and malignancy, oncogenes, tumor silencers, oncogenic cofactors, interruption of natural/flexible insusceptible reactions, idleness, viral mimicry/robbery of cellular administrative traits, genomic unsteadiness and job of non-coding RNAs in viral pathogenesis. The motive for this exam is to create viral vectors for human disease fine remedy and to develop antibody structures for therapy of viral-associated tumors. A few strategies are being accompanied incorporating hereditary vaccination with recombinant viral vectors dependent on Semliki wooded area contamination, resistant checkpoint inhibitors and processes to re-alter the immunosuppressive tumor weather.

  • Viral mimicry of genes
  • Principle investigator
  • Viral therapy
  • Viral-associated cancers

Related Conference of Tumor Virology

March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France

Tumor Virology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in